Medtech, pharma industries decry Spanish revision of healthcare products access law
This article was originally published in Clinica
Executive Summary
Emergency austerity-driven amendments to a central piece of Spanish legislation which impacts on patient access to healthcare products have been roundly criticised by the medical technology and pharma industries, despite their acknowledgement of the utmost need to tackle the economic pressures facing the country.